Therapeutic Options for Neuroendocrine Tumors
نویسندگان
چکیده
منابع مشابه
New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare, generally indolent neoplasms that can arise throughout the gastrointestinal system. Some GEP-NETs, known as functional, secrete hormones that can lead to a complex of symptoms. Classical carcinoid syndrome is associated with flushing, diarrhea, bronchospasm, and symptoms of valvular heart disease. GEP-NETs are classified accordin...
متن کاملNeuroendocrine tumors.
Neuroendocrine tumors comprise a broad family of tumors, the most common of which are carcinoid and pancreatic neuroendocrine tumors. The NCCN Neuroendocrine Tumors Guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine tumors. Most of the recommendations pertain to well-differentiated, low- to intermediate-grade tumors. This updated version of the NCCN G...
متن کاملMetastatic brain tumors: current therapeutic options and historical perspective.
Metastatic brain tumors affect more than 150,000 patients annually in the United States. The therapeutic paradigms for these tumors have evolved over the years and currently encompass numerous modalities implemented by treating physicians across several medical disciplines. The armamentarium of brain tumor treatment involves neurosurgical intervention, whole-brain and focused radiation modaliti...
متن کاملBiochemical testing for neuroendocrine tumors.
In this review, we focus on the use of biochemical markers for the diagnosis of neuroendocrine tumors and exclusion of conditions that masquerade as neuroendocrine tumors. In addition, we outline the use of biochemical markers for follow-up, response to intervention, and determination of prognosis. Previous publications have focused only on markers specific to certain tumor types, but the uniqu...
متن کاملNeuroendocrine Tumors
Nalân Utku1* and Ulrich Frank Pape2 1Campus Virchow Institute for Medical Immunology, Institutsgebäude Süd Föhrer, 213353 Berlin, Germany 2Campus Mitte and Virchow, Charité Comprehensive Cancer Center and Gastrophatology2, Charite, Berlin, Germany *Corresponding author: Nalân Utku, Campus Virchow Institute for Medical Immunology, Institutsgebäude Süd Föhrer, 213353 Berlin, Germany; E-mail: nala...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA Oncology
سال: 2019
ISSN: 2374-2437
DOI: 10.1001/jamaoncol.2018.6720